SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: billy d who wrote (1757)2/18/1999 4:54:00 PM
From: BMcV  Read Replies (1) | Respond to of 10280
 
I share your reservations, billy. They seem to be making a lot of favorable assumptions. I hope they have good reason for doing so. Watching the company the past few years, however, has given me a lot of faith in management.

CNBC will have David Southwell on Squawk Box at 9:10 tomorrow.



To: billy d who wrote (1757)2/18/1999 5:27:00 PM
From: dave g  Read Replies (2) | Respond to of 10280
 
Sepracor's trials

Are a much safer bet than developing a drug from the ground up. They are simply tweaking a drug that already is out there being used. Plus the FDA has been pushing drug companies to come up with single isomer drugs because the have been proven to have less side effects. This company is awesome.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News